Form 8-K · Current report
U.S. Bancorp 8-K, filed Jul 16, 2026
- Filed
- CIK
- 0000036104
- Accession no.
- 0000036104-26-000039
Summary
U.S. Bancorp reported second-quarter 2026 net income of $2,177 million, or $1.35 per diluted common share, up 22% from a year earlier, on record net revenue of $7,712 million, and said it completed its acquisition of BTIG effective June 1, 2026. CEO Gunjan Kedia attributed the quarter to loan growth, fee income momentum and positive operating leverage, and said credit quality continues to improve.
Key points
- Net revenue was a record $7,712 million, with net interest income up 7.5% and fee revenue up 13.2% year over year.
- Net interest margin rose to 2.79% from 2.66% a year earlier; return on average assets was 1.26% and the efficiency ratio 57.1%.
- Average total loans increased 7.1% year over year to $405,481 million and average total deposits rose 2.4% to $515,080 million; the CET1 capital ratio was 10.8%.
- The BTIG acquisition closed effective June 1, 2026, contributing about $98 million in fee revenue and $84 million of noninterest expense; U.S. Bancorp also held an investor conference call on July 16, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On July 16, 2026, U.S. Bancorp (the “Company”) issued a press release reporting financial results for the quarter ended June 30, 2026. The press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference. The press release contains forward-looking statements regarding the Company and includes a cautionary statement identifying important factors that could cause actual results to differ materially from those anticipated. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.